{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:19:52Z","timestamp":1783131592465,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,30]],"date-time":"2027-04-30T00:00:00Z","timestamp":1809043200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014479","name":"Georgia Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA086862"],"award-info":[{"award-number":["P30 CA086862"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU58DP007156"],"award-info":[{"award-number":["1NU58DP007156"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.leukres.2026.108238","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:52:59Z","timestamp":1777463579000},"page":"108238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the value of measuring frailty in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5758-2804","authenticated-orcid":false,"given":"Vanessa E.","family":"Slater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-7686","authenticated-orcid":false,"given":"Bradley D.","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chrischilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108238_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.02.001","article-title":"Management of unfit elderly patients with chronic lymphocytic leukemia","volume":"58","author":"Eichhorst","year":"2018","journal-title":"Eur. J. Intern Med"},{"key":"10.1016\/j.leukres.2026.108238_bib2","unstructured":"Cancer Stat Facts: Leukemia - Chronic Lymphocytic Leukemia. Available from: \u3008https:\/\/seer.cancer.gov\/statfacts\/html\/clyl.html\u3009."},{"issue":"5","key":"10.1016\/j.leukres.2026.108238_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jgo.2016.07.007","article-title":"New treatment approaches in CLL: Challenges and opportunities in the elderly","volume":"7","author":"Eichhorst","year":"2016","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.leukres.2026.108238_bib4","unstructured":"Key Statistics for Chronic Lymphocytic Leukemia. 2023 [cited 2023 Nov 29]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/chronic-lymphocytic-leukemia\/about\/key-statistics.html\u3009."},{"issue":"15","key":"10.1016\/j.leukres.2026.108238_bib5","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1002\/cncr.31554","article-title":"Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib","volume":"124","author":"Gordon","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.14785","article-title":"Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study","volume":"178","author":"Strati","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"24","key":"10.1016\/j.leukres.2026.108238_bib7","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1182\/bloodadvances.2021004824","article-title":"Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?","volume":"5","author":"Tedeschi","year":"2021","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.leukres.2026.108238_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18020701","article-title":"Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study","volume":"18","author":"Villavicencio","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"issue":"6","key":"10.1016\/j.leukres.2026.108238_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.2013.096792","article-title":"Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials","volume":"99","author":"Goede","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.leukres.2026.108238_bib10","article-title":"Additional malignancies shorten overall survival in chronic lymphocytic leukemia irrespective of chromosomal aberrations: A retrospective cohort study","volume":"102","author":"Turan Erkek","year":"2023","journal-title":"Med. (Baltim. )"},{"issue":"2","key":"10.1016\/j.leukres.2026.108238_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ejh.13720","article-title":"Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study","volume":"108","author":"Steingr\u00edmsson","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108238_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/10428194.2015.1091933","article-title":"Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group","volume":"57","author":"Goede","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.leukres.2026.108238_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101538","article-title":"Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia","volume":"14","author":"Johnson","year":"2023","journal-title":"J. Geriatr. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108238_bib14","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1002\/cam4.3855","article-title":"Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population","volume":"10","author":"Goyal","year":"2021","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.leukres.2026.108238_bib15","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/cam4.2268","article-title":"Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States","volume":"8","author":"Kabadi","year":"2019","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.leukres.2026.108238_bib16","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41375-021-01156-x","article-title":"Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death","volume":"35","author":"Rotbain","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2026.108238_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13690-015-0068-x","article-title":"Burden of frailty in the elderly population: perspectives for a public health challenge","volume":"73","author":"Buckinx","year":"2015","journal-title":"Arch. Public Health"},{"issue":"9868","key":"10.1016\/j.leukres.2026.108238_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cger.2017.02.002","article-title":"Frailty in Older Persons","volume":"33","author":"Cesari","year":"2017","journal-title":"Clin. Geriatr. Med"},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib21","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"10206","key":"10.1016\/j.leukres.2026.108238_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.leukres.2026.108238_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108238_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106869","article-title":"Mammography adherence in relation to function-related indicators in older women","volume":"154","author":"Zhang","year":"2022","journal-title":"Prev. Med"},{"issue":"8","key":"10.1016\/j.leukres.2026.108238_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101602","article-title":"Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study","volume":"14","author":"Duchesneau","year":"2023","journal-title":"J. Geriatr. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib26","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/MLR.0000000000000026","article-title":"Beyond comorbidity: expanding the definition and measurement of complexity among older adults using administrative claims data","volume":"52","author":"Chrischilles","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2026.108238_bib27","article-title":"Sociodemographic and clinical characteristics associated with rehabilitation services utilization in older women with early-stage breast cancer from SEER-Medicare 2009-2018","author":"Gorzelitz","year":"2024","journal-title":"J. Cancer Surviv"},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib28","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.clbc.2019.09.005","article-title":"Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence","volume":"20","author":"Haskins","year":"2020","journal-title":"Clin. Breast Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2026.108238_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.juro.2016.12.012","article-title":"Patient Function and the Value of Surgical Care for Kidney Cancer","volume":"197","author":"Tan","year":"2017","journal-title":"J. Urol."},{"issue":"24","key":"10.1016\/j.leukres.2026.108238_bib30","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.30275","article-title":"Patient function, long-term survival, and use of surgery in patients with kidney cancer","volume":"122","author":"Tan","year":"2016","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.leukres.2026.108238_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027288","article-title":"Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study","volume":"11","author":"Herbach","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.leukres.2026.108238_bib32","unstructured":"SEER-Medicare: How the SEER & Medicare Data are Linked. 2020 [cited 2023 2\/21]; Available from: \u3008https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/overview\/linked.html\u3009."},{"key":"10.1016\/j.leukres.2026.108238_bib33","unstructured":"Registry Groupings in SEER Data and Statistics. [cited 2024 03\/25]; Available from: \u3008https:\/\/seer.cancer.gov\/registries\/terms.html\u3009."},{"key":"10.1016\/j.leukres.2026.108238_bib34","unstructured":"SEER-Medicare: Comorbidity SAS Macros. 2023 [cited 2023 Nov 30]; Available from: \u3008https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/calculation.html\u3009."},{"key":"10.1016\/j.leukres.2026.108238_bib35","unstructured":"Building Internal Processes and Planning Validation Activities Related to Use of ICD-10-CM Codes in the Sentinel Initiative. 2018 [cited 2020 1\/22]; Available from: \u3008https:\/\/www.sentinelinitiative.org\/methods-data-tools\/methods\/building-internal-processes-and-planning-validation-activities-related\u3009."},{"issue":"8","key":"10.1016\/j.leukres.2026.108238_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.9679","article-title":"Measurement of Fall Injury With Health Care System Data and Assessment of Inclusiveness and Validity of Measurement Models","volume":"2","author":"Min","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.leukres.2026.108238_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MLR.0000000000000531","article-title":"Claims-based Identification Methods and the Cost of Fall-related Injuries Among US Older Adults","volume":"54","author":"Hoffman","year":"2016","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.leukres.2026.108238_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/gerona\/glab274","article-title":"Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data","volume":"77","author":"Mintz","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"1","key":"10.1016\/j.leukres.2026.108238_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2010.08.008","article-title":"Frailty defined by deficit accumulation and geriatric medicine defined by frailty","volume":"27","author":"Rockwood","year":"2011","journal-title":"Clin. Geriatr. Med"},{"issue":"8","key":"10.1016\/j.leukres.2026.108238_bib40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1055-9965.EPI-21-0152","article-title":"Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort","volume":"30","author":"Zhang","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.leukres.2026.108238_bib41","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Chronic Lymphocytic Leukemia","year":"2022"},{"issue":"7","key":"10.1016\/j.leukres.2026.108238_bib42","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s12325-020-01350-w","article-title":"Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study","volume":"37","author":"Kabadi","year":"2020","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.leukres.2026.108238_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PPO.0000000000000407","article-title":"Real-World Evidence for Chronic Lymphocytic Leukemia in the Era of Targeted Therapies","volume":"25","author":"Islam","year":"2019","journal-title":"Cancer J."},{"issue":"3","key":"10.1016\/j.leukres.2026.108238_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jgs.13953","article-title":"Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction","volume":"64","author":"Chrischilles","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.leukres.2026.108238_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaccao.2023.09.002","article-title":"Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia","volume":"5","author":"Quartermaine","year":"2023","journal-title":"JACC CardioOncology State---Art. Rev. JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.leukres.2026.108238_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063319","article-title":"Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions","volume":"25","author":"Wang","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.leukres.2026.108238_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trsl.2020.03.013","article-title":"Frailty and aging in cancer survivors","volume":"221","author":"Ness","year":"2020","journal-title":"Transl. Res"},{"issue":"13","key":"10.1016\/j.leukres.2026.108238_bib48","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.2023020195","article-title":"Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL","volume":"142","author":"van der Straten","year":"2023","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.leukres.2026.108238_bib49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood.2023021370","article-title":"Frailty is also a target for targeted drugs in CLL","volume":"142","author":"Goede","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2026.108238_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review","volume":"329","author":"Shadman","year":"2023","journal-title":"Jama"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:44:41Z","timestamp":1783129481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S0145212626000822"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108238","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the value of measuring frailty in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108238"}}